(Q44468693)

3 December 2017

Target site bacterial killing of cefpirome and fosfomycin in critically ill patients (English)

1 reference

3 December 2017

M A Zeitlinger

1

1 reference

3 December 2017

C Marsik

2

1 reference

3 December 2017

A Georgopoulos

3

1 reference

3 December 2017

M Müller

4

1 reference

3 December 2017

G Heinz

5

1 reference

3 December 2017

C Joukhadar

6

1 reference

3 December 2017

1 June 2003

1 reference

International Journal of Antimicrobial Agents

3 December 2017

1 reference

3 December 2017

21

1 reference

3 December 2017

6

1 reference

3 December 2017

562-567

1 reference

Antibiotic susceptibility and resistance testing: an overview

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

In vitro activity of fosfomycin in combination with various antistaphylococcal substances.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

Target site penetration of fosfomycin in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

Distribution and antimicrobial activity of ciprofloxacin in human soft tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

Target site concentrations after continuous infusion and bolus injection of cefpirome to healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

Surgery and intensive care procedures affect the target site distribution of piperacillin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

Tissue distribution of imipenem in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

Developments in PK/PD: optimising efficacy and prevention of resistance. A critical review of PK/PD in in vitro models

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

Evaluation of fosfomycin in an intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

Combined Action of Fosfomycin with <i>β</i>-Lactam and Aminoglycoside Antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

Fosfomycin: Laboratory Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

The Action of Fosfomycin on the Growth of <i>Pseudomonas aeruginosa</i>

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

Mechanisms of bacterial resistance to antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900047-5

7 January 2021

10.1016/S0924-8579(03)00047-5

Identifiers

DOI

1 reference

3 December 2017

1 reference